Neil E. Fleshner - 28 Mar 2023 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Chief Medical Officer, Director
Signature
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
Issuer symbol
N/A
Transactions as of
28 Mar 2023
Net transactions value
$0
Form type
4
Filing time
30 Mar 2023, 20:07:37 UTC
Previous filing
26 May 2022
Next filing
02 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +84,257 $0.000000 84,257 28 Mar 2023 Common Stock 84,257 $6.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.